Eloxatin™ (oxaliplatin for injection) approved in the United States for the 1st line treatment of metastatic colorectal cancer | Oxaliplatin – Eloxatin® – Elplat® | / | Press Releases

Menu Content/Inhalt

Home|Careers|Contact us

Social responsibility

Development capabilites

Commercial Products

News

Oxaliplatin – Eloxatin® – Elplat®

PRESS RELEASES

Eloxatin™ (oxaliplatin for injection) approved in the United States for the 1st line treatment of metastatic colorectal cancer

link to sanofi-synthelabo's press release of 12th January, 2004